اشترك بالحزمة الذهبية واحصل على وصول غير محدود شمرا أكاديميا
تسجيل مستخدم جديدHidden Stratification Causes Clinically Meaningful Failures in Machine Learning for Medical Imaging
83
0
0.0
(
0
)
اسأل ChatGPT حول البحث
ﻻ يوجد ملخص باللغة العربية
Machine learning models for medical image analysis often suffer from poor performance on important subsets of a population that are not identified during training or testing. For example, overall performance of a cancer detection model may be high, but the model still consistently misses a rare but aggressive cancer subtype. We refer to this problem as hidden stratification, and observe that it results from incompletely describing the meaningful variation in a dataset. While hidden stratification can substantially reduce the clinical efficacy of machine learning models, its effects remain difficult to measure. In this work, we assess the utility of several possible techniques for measuring and describing hidden stratification effects, and characterize these effects on multiple medical imaging datasets. We find evidence that hidden stratification can occur in unidentified imaging subsets with low prevalence, low label quality, subtle distinguishing features, or spurious correlates, and that it can result in relative performance differences of over 20% on clinically important subsets. Finally, we explore the clinical implications of our findings, and suggest that evaluation of hidden stratification should be a critical component of any machine learning deployment in medical imaging.
قيم البحث
اقرأ أيضاً
Most state-of-the-art machine learning algorithms induce black-box models, preventing their application in many sensitive domains. Hence, many methodologies for explaining machine learning models have been proposed to address this problem. In this wo
rk, we introduce strategies to improve local explanations taking into account the distribution of the data used to train the black-box models. We show that our approach, MeLIME, produces more meaningful explanations compared to other techniques over different ML models, operating on various types of data. MeLIME generalizes the LIME method, allowing more flexible perturbation sampling and the use of different local interpretable models. Additionally, we introduce modifications to standard training algorithms of local interpretable models fostering more robust explanations, even allowing the production of counterfactual examples. To show the strengths of the proposed approach, we include experiments on tabular data, images, and text; all showing improved explanations. In particular, MeLIME generated more meaningful explanations on the MNIST dataset than methods such as GuidedBackprop, SmoothGrad, and Layer-wise Relevance Propagation. MeLIME is available on https://github.com/tiagobotari/melime.
Advances in computing power, deep learning architectures, and expert labelled datasets have spurred the development of medical imaging artificial intelligence systems that rival clinical experts in a variety of scenarios. The National Institutes of H
ealth in 2018 identified key focus areas for the future of artificial intelligence in medical imaging, creating a foundational roadmap for research in image acquisition, algorithms, data standardization, and translatable clinical decision support systems. Among the key issues raised in the report: data availability, need for novel computing architectures and explainable AI algorithms, are still relevant despite the tremendous progress made over the past few years alone. Furthermore, translational goals of data sharing, validation of performance for regulatory approval, generalizability and mitigation of unintended bias must be accounted for early in the development process. In this perspective paper we explore challenges unique to high dimensional clinical imaging data, in addition to highlighting some of the technical and ethical considerations in developing high-dimensional, multi-modality, machine learning systems for clinical decision support.
With the rising use of Machine Learning (ML) and Deep Learning (DL) in various industries, the medical industry is also not far behind. A very simple yet extremely important use case of ML in this industry is for image classification. This is importa
nt for doctors to help them detect certain diseases timely, thereby acting as an aid to reduce chances of human judgement error. However, when using automated systems like these, there is a privacy concern as well. Attackers should not be able to get access to the medical records and images of the patients. It is also required that the model be secure, and that the data that is sent to the model and the predictions that are received both should not be revealed to the model in clear text. In this study, we aim to solve these problems in the context of a medical image classification problem of detection of pneumonia by examining chest x-ray images.
Strong empirical evidence that one machine-learning algorithm A outperforms another one B ideally calls for multiple trials optimizing the learning pipeline over sources of variation such as data sampling, data augmentation, parameter initialization,
and hyperparameters choices. This is prohibitively expensive, and corners are cut to reach conclusions. We model the whole benchmarking process, revealing that variance due to data sampling, parameter initialization and hyperparameter choice impact markedly the results. We analyze the predominant comparison methods used today in the light of this variance. We show a counter-intuitive result that adding more sources of variation to an imperfect estimator approaches better the ideal estimator at a 51 times reduction in compute cost. Building on these results, we study the error rate of detecting improvements, on five different deep-learning tasks/architectures. This study leads us to propose recommendations for performance comparisons.
The recent advancements in machine learning (ML) have demonstrated the potential for providing a powerful solution to build complex prediction systems in a short time. However, in highly regulated industries, such as the financial technology (Fintech
), people have raised concerns about the risk of ML systems discriminating against specific protected groups or individuals. To address these concerns, researchers have introduced various mathematical fairness metrics and bias mitigation algorithms. This paper discusses hidden technical debts and challenges of building fair ML systems in a production environment for Fintech. We explore various stages that require attention for fairness in the ML system development and deployment life cycle. To identify hidden technical debts that exist in building fair ML system for Fintech, we focus on key pipeline stages including data preparation, model development, system monitoring and integration in production. Our analysis shows that enforcing fairness for production-ready ML systems in Fintech requires specific engineering commitments at different stages of ML system life cycle. We also propose several initial starting points to mitigate these technical debts for deploying fair ML systems in production.
الأسئلة المقترحة
سجل دخول لتتمكن من نشر تعليقات
التعليقات
جاري جلب التعليقات
سجل دخول لتتمكن من متابعة معايير البحث التي قمت باختيارها
